Related references
Note: Only part of the references are listed.Epithelial desquamation observed in a phase I study of an oral cathepsin C inhibitor (GSK2793660)
Bruce E. Miller et al.
BRITISH JOURNAL OF CLINICAL PHARMACOLOGY (2017)
The Role of Neutrophil Elastase Inhibitors in Lung Diseases
Eva Polverino et al.
CHEST (2017)
Neutrophil Elastase Activity Is Associated with Exacerbations and Lung Function Decline in Bronchiectasis
James D. Chalmers et al.
AMERICAN JOURNAL OF RESPIRATORY AND CRITICAL CARE MEDICINE (2017)
Prolonged pharmacological inhibition of cathepsin C results in elimination of neutrophil serine proteases
Carla Guarino et al.
BIOCHEMICAL PHARMACOLOGY (2017)
Neutrophil maturation rate determines the effects of dipeptidyl peptidase 1 inhibition on neutrophil serine protease activity
P. Gardiner et al.
BRITISH JOURNAL OF PHARMACOLOGY (2016)
Granulopoiesis and granules of human neutrophils
Jack B. Cowland et al.
IMMUNOLOGICAL REVIEWS (2016)
Neutrophilic Cathepsin C Is Maturated by a Multistep Proteolytic Process and Secreted by Activated Cells during Inflammatory Lung Diseases
Yveline Hamon et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2016)
Discovery of Second Generation Reversible Covalent DPP1 Inhibitors Leading to an Oxazepane Amidoacetonitrile Based Clinical Candidate (AZD7986)
Kevin Doyle et al.
JOURNAL OF MEDICINAL CHEMISTRY (2016)
Allpha1-antitrypsin Review
Robert A. Stockley
CLINICS IN CHEST MEDICINE (2014)
Papillon-Lefevre syndrome patient reveals species-dependent requirements for neutrophil defenses
Ole E. Sorensen et al.
JOURNAL OF CLINICAL INVESTIGATION (2014)
Proteases and proteomics: Cutting to the core of human skin pathologies
Simon J. de Veer et al.
PROTEOMICS CLINICAL APPLICATIONS (2014)
Neutrophil Elastase-Mediated Lung Disease
Robert A. Sandhaus et al.
COPD-JOURNAL OF CHRONIC OBSTRUCTIVE PULMONARY DISEASE (2013)
Pharmacokinetics and safety of AZD9668, an oral neutrophil elastase inhibitor, in healthy volunteers and patients with COPD
Kulasiri A. Gunawardena et al.
INTERNATIONAL JOURNAL OF CLINICAL PHARMACOLOGY AND THERAPEUTICS (2013)
A Randomised, Placebo-Controlled, Dose-Finding Study Of AZD9668, An Oral Inhibitor of Neutrophil Elastase, in Patients with Chronic Obstructive Pulmonary Disease Treated with Tiotropium
Claus Vogelmeier et al.
COPD-JOURNAL OF CHRONIC OBSTRUCTIVE PULMONARY DISEASE (2012)
Neutrophil Activation in Severe, Early-Onset COPD Patients versus Healthy Non-Smoker Subjects in vitro: Effects of Antioxidant Therapy
Javier Milara et al.
RESPIRATION (2012)
Prediction-Corrected Visual Predictive Checks for Diagnosing Nonlinear Mixed-Effects Models
Martin Bergstrand et al.
AAPS JOURNAL (2011)
Eponym Papillon-Lefevre syndrome
Buket Dalgic et al.
EUROPEAN JOURNAL OF PEDIATRICS (2011)
Interpretation of transit compartments pharmacodynamic models as lifespan based indirect response models
Wojciech Krzyzanski
JOURNAL OF PHARMACOKINETICS AND PHARMACODYNAMICS (2011)
Neutrophil Elastase, Proteinase 3, and Cathepsin G as Therapeutic Targets in Human Diseases
Brice Korkmaz et al.
PHARMACOLOGICAL REVIEWS (2010)
Neutrophil kinetics in health and disease
Charlotte Summers et al.
TRENDS IN IMMUNOLOGY (2010)
Effects of Drug Transporters on Volume of Distribution
Anita Grover et al.
AAPS JOURNAL (2009)
In vivo inhibition of serine protease processing requires a high fractional inhibition of cathepsin C
Nathalie Methot et al.
MOLECULAR PHARMACOLOGY (2008)
Inhibition of the activation of multiple serine proteases with a cathepsin C inhibitor requires sustained exposure to prevent pro-enzyme processing
Nathalie Methot et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2007)
Human neutrophil elastase induces hypersecretion of mucin from well-differentiated human bronchial epithelial cells in vitro via a protein kinase Cδ-mediated mechanism
JA Park et al.
AMERICAN JOURNAL OF PATHOLOGY (2005)
Papillon-Lefevre syndrome: Correlating the molecular, cellular, and clinical consequences of cathepsin C/dipeptidyl peptidase I deficiency in humans
CTN Pham et al.
JOURNAL OF IMMUNOLOGY (2004)
The ABCs of drug transport in intestine and liver: efflux proteins limiting drug absorption and bioavailability
LMS Chan et al.
EUROPEAN JOURNAL OF PHARMACEUTICAL SCIENCES (2004)
The role of cathepsin C in Papillon-Lefevre syndrome, prepubertal periodontitis, and aggressive periodontitis
C Hewitt et al.
HUMAN MUTATION (2004)
Role of P-glycoprotein in pharmacokinetics - Clinical implications
JH Lin et al.
CLINICAL PHARMACOKINETICS (2003)
Share Paper
